The Food Effect on Pharmacokinetics of DA-302168S

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

August 3, 2024

Study Completion Date

August 3, 2024

Conditions
Overweight and Obesity
Interventions
DRUG

15 mg DA-302168S tablet

"Qualified subjects will be randomly assigned to one of two dosing sequences in a 1:1 ratio. Either DA-302168S tablet with food on Day 1 and DA-302168S tablet without food on Day 6 (treatment sequence fed/fasted), or DA-302168S tablet without food on Day 1 and DA-302168S tablet with food on Day 6 (treatment sequence fasted/fed).~Each administration sequence consists of two cycles, with one administration per cycle and a 5-day washout period between each administration."

Trial Locations (1)

210008

Gulou Hospital Affiliated to Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Chendu DIAO Pharmaceutical Group CO., LTD.

INDUSTRY

NCT06534346 - The Food Effect on Pharmacokinetics of DA-302168S | Biotech Hunter | Biotech Hunter